back to all entries

A Hysterectomy Is Not Always the Best Option for Women With Fibroids: Real Health Magazine

June 06,2022

Ron-Ella McLendon first experienced menstrual cycle difficulties while she was in high school. “I was going through three to four pads each hour, and I used to pass out a lot in school,” recalls the government contractor, life coach and author, age 43. “Doctors would tell me that my iron was low.

In McLendon’s family circles, the health condition wasn’t discussed much. “I’d heard of fibroids, but I never knew in depth what they were,” she says. “Talking about it was kind of taboo.”

“Patients seeking information about fibroid treatment other than removing their uterus tell us that they have received little if any information on hysterectomy alternatives and the risks that a major surgery poses,” says Yan Katsnelson, MD, founder of Fibroid Fighters Foundation, an advocacy group dedicated to educating the public about the impact of fibroid disease and safe and effective minimally invasive treatments for the condition.

Read the entire article here:

https://www.realhealthmag.com/article/hysterectomy-option-women-fibroids

Other Posts

ABCNewsLinseyDavisRoundtableDiscussion
09/08/25

ABC News Hosts Roundtable on Fibroids with Linsey Davis, Cynthia Bailey, and Tamar Braxton 

Recently on ABC News, a roundtable conversation took place featuring anchor Linsey Davis, model and actress Cynthia Bailey, and singer Tamar Braxton, who each shared their personal experiences living with

FeasabilityOfSameDayDischargeAfterMyomectomy
09/08/25

Researchers Explore Same-Day Discharge After Myomectomy 

A new study is examining whether patients undergoing myomectomy—the surgical removal of fibroids—can safely return home the same day instead of staying overnight in the hospital. Researchers found promising evidence

The U-FIGHT Act represents a significant leap forward in uterine health advocacy.
09/03/25

Fighting for Fibroid Research—The U-FIGHT Act

Senator Angela Alsobrooks’s message is clear: Fibroids affect up to 80% of women, yet a staggering 0.03% of federal research funding goes toward studying them. Fibroids impact 80% of women